 |
市场调查报告书
商品编码
1890935
放射肿瘤市场按治疗方法、技术、应用、最终用户和地区划分Radiation Oncology Market, By Therapy Type, By Technology, By Application, By End User, By Geography |
||||||
预计到 2025 年，放射肿瘤学市场价值将达到 125.1 亿美元，预计到 2032 年将达到 163.1 亿美元，2025 年至 2032 年的复合年增长率为 11.2%。
| 报告内容 | 报告详情 | ||
|---|---|---|---|
| 基准年： | 2024 | 2025年市场规模： | 125.1亿美元 |
| 历史数据时期： | 2020年至2024年 | 预测期： | 2025年至2032年 |
| 预测期（2025-2032年）复合年增长率： | 11.20% | 2032 年的预测值： | 163.1亿美元 |
全球放射肿瘤市场是医疗产业的重要组成部分，涵盖了透过精准放射治疗系统进行癌症治疗的先进医疗技术和治疗方案。放射肿瘤学是一门利用高能量放射线束摧毁癌细胞，同时最大限度地减少对周围健康组织损伤的医学专科，使其成为全面癌症治疗通讯协定的重要组成部分。该市场包含各种先进设备，例如线性加速器、近距离放射机、质子治疗系统和立体定位放射放射线手术机，以及支援治疗计划和患者管理的软体解决方案。
人口老化、生活方式改变和环境因素导致全球癌症负担日益加重，使得放射肿瘤学成为现代癌症治疗的基石。世界各地的医疗机构都在大力投资最先进的放射治疗设备，以提高治疗精度、减少副作用并改善患者预后。这个市场发展的特点是技术的不断进步，例如影像导航放射治疗（IGRT）、强度调控放射治疗（IMRT）以及人工智慧的融合应用，这些技术共同促成了更个人化和有效的癌症治疗方法，使放射肿瘤学成为全球医疗保健领域中一个至关重要且快速发展的领域。
市场动态
全球放射肿瘤市场受多种强劲因素驱动，维持稳健的成长动能。其中，全球癌症发生率的不断攀升是主要驱动因素，这需要复杂的治疗性介入，并导致全球医疗机构对先进放射治疗设备的需求显着增长。人口老化也是关键的人口因素，癌症发生率随年龄增长而显着上升，从而持续推动医院和专科癌症治疗中心对放射肿瘤服务和设备升级的需求。技术创新也是重要的成长要素，精准医疗、人工智慧整合、影像导航放射治疗和质子治疗等领域的突破性进展，在提高治疗效果的同时降低了副作用，促使医疗机构投资于新一代放射肿瘤解决方案。
然而，市场也面临许多製约因素。购置和安装先进放射治疗设备所需的高昂资本成本，尤其会对医疗预算造成巨大压力，并限制新兴市场和小规模医疗机构的普及率。此外，合格的放射肿瘤科医师、医学物理学家和训练有素的技术人员短缺，也造成了营运方面的限制，阻碍了市场扩张。而且，新放射治疗技术严格的监管核准流程可能会延迟产品上市和市场渗透。儘管有这些挑战，但由于许多机会，放射肿瘤市场预计将维持长期持续成长。这些机会包括开发中国家医疗基础设施的扩建、政府主导的癌症治疗改善计划的增加、针对先进癌症治疗的医疗旅游的兴起，以及提高治疗效率和患者便利性的分次放射治疗技术的广泛应用。
本次调查的主要特点
- 本报告对全球放射肿瘤市场进行了详细分析，以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模（十亿美元）和復合年增长率（%）。
- 它重点介绍了各个细分市场的潜在商机，并说明了该市场具有吸引力的投资提案矩阵。
- 该研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或核准、市场趋势、区域展望以及主要企业采取的竞争策略的重要见解。
- 该报告根据以下参数对全球放射肿瘤学市场的主要企业进行了分析：公司概况、产品系列、主要亮点、财务表现和策略。
- 本报告的研究结果将使负责人和企业经营团队能够就未来的产品发布、设备升级、市场扩张和行销策略做出明智的决策。
- 这份全球放射肿瘤市场报告针对该行业的各种相关人员，包括投资者、供应商、产品製造商、经销商、新参与企业和金融分析师。
- 相关人员可以透过各种用于分析全球放射肿瘤市场的策略矩阵，更轻鬆地做出决策。
目录
第一章 研究目标与前提条件
- 调查目的
- 先决条件
- 简称
第二章 市场范围
- 报告概述
- 市场定义和范围
- 执行摘要
第三章 市场动态、监理及趋势分析
- 市场动态
- 司机
- 抑制因素
- 机会
- 影响分析
- 重大进展
- 法规环境
- 产品上市及核准
- PEST分析
- 波特分析
- 併购趋势
- 产业趋势
4. 2020-2032年全球放射肿瘤市场（依治疗方法）
- 体外放射治疗（EBRT）
- 体内放射治疗（近距离放射治疗/体内照射）
- 质子束/重粒子束疗法
- 放射性药物和全身放射线治疗
5. 2020-2032年全球放射肿瘤市场（依技术划分）
- 3D适形放射治疗（3D CRT）
- 强度调控放射治疗（IMRT）
- 容积调强弧形治疗（VMAT）
- 影像导航放射治疗（IGRT）
- 立体定位放射治疗（SRS/SBRT）
- 高剂量率（HDR）/低剂量率（LDR）近距离放射
- 自适应放射治疗/即时肿瘤追踪
6. 2020-2032年全球放射肿瘤市场（依应用领域划分）
- 乳癌
- 肺癌
- 摄护腺癌
- 头颈癌
- 大肠直肠癌
- 妇科癌症
- 其他癌症（例如，皮肤癌、脑瘤、胰臟癌、罕见肿瘤等）
7. 2020-2032年全球放射肿瘤市场（依最终用户划分）
- 医院（癌症及放射治疗科）
- 专业肿瘤及放射治疗中心
- 门诊放射治疗诊所
- 研究机构和大学
8. 2020-2032年全球放射肿瘤市场（依地区划分）
- 北美洲
- 美国
- 加拿大
- 拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲国家
- 欧洲
- 德国
- 英国
- 西班牙
- 法国
- 义大利
- 俄罗斯
- 其他欧洲
- 亚太地区
- 中国
- 印度
- 日本
- 澳洲
- 韩国
- ASEAN
- 亚太其他地区
- 中东
- 海湾合作委员会国家
- 以色列
- 其他中东国家
- 非洲
- 南非
- 北非
- 中非
第九章 竞争情势
- Varian Medical Systems Inc.
- Elekta AB
- Accuray Incorporated
- Mevion Medical Systems
- ViewRay Technologies Inc.
- Isoray Inc.
- Hitachi Ltd.
- IBA（Ion Beam Applications SA）
- Nordion Inc.
- Brainlab SE
- Xstrahl Ltd.
- Panacea Medical Technologies Pvt. Ltd.
- Siemens Healthineers AG
- GE HealthCare
- Bionix Radiation Therapy LLC
第十章 分析师建议
- 机会
- 分析师观点
- Coherent Opportunity Map
第十一章 参考文献与调查方法
- 参考
- 调查方法
- 关于出版商
Radiation Oncology Market is estimated to be valued at USD 12.51 Bn in 2025 and is expected to reach USD 16.31 Bn by 2032, growing at a compound annual growth rate (CAGR) of 11.2% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 12.51 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 11.20% | 2032 Value Projection: | USD 16.31 Bn |
The global radiation oncology market represents a critical segment of the healthcare industry, encompassing advanced medical technologies and therapeutic solutions designed to combat cancer through precise radiation delivery systems. Radiation oncology, as a specialized field of medicine, utilizes high-energy radiation beams to destroy malignant cells while minimizing damage to surrounding healthy tissues, making it an indispensable component of comprehensive cancer treatment protocols. This market encompasses a diverse array of sophisticated equipment including linear accelerators, brachytherapy devices, proton therapy systems, and stereotactic radiosurgery units, alongside supporting software solutions for treatment planning and patient management.
The increasing global cancer burden, driven by aging populations, lifestyle changes, and environmental factors, has positioned radiation oncology as a cornerstone of modern oncological care. Healthcare institutions worldwide are investing substantially in state-of-the-art radiation therapy equipment to enhance treatment precision, reduce side effects, and improve patient outcomes. The market's evolution is characterized by continuous technological advancements, including image-guided radiation therapy (IGRT), intensity-modulated radiation therapy (IMRT), and artificial intelligence integration, which collectively contribute to more personalized and effective cancer treatment approaches, establishing radiation oncology as an essential and rapidly expanding segment within the global healthcare landscape.
Market Dynamics
The global radiation oncology market is propelled by several compelling drivers that collectively fuel its robust growth trajectory, primarily anchored by the escalating global cancer incidence rates, which necessitate advanced therapeutic interventions and drive substantial demand for sophisticated radiation therapy equipment across healthcare facilities worldwide. The aging global population presents a significant demographic driver, as cancer prevalence increases substantially with age, creating sustained demand for radiation oncology services and equipment upgrades in hospitals and specialized cancer treatment centers. Technological innovations serve as another pivotal growth driver, with breakthrough developments in precision medicine, artificial intelligence integration, image-guided radiation therapy, and proton beam therapy enhancing treatment efficacy while reducing adverse effects, thereby encouraging healthcare institutions to invest in next-generation radiation oncology solutions.
However, the market faces notable restraints including the exceptionally high capital costs associated with acquiring and installing advanced radiation therapy equipment, which can strain healthcare budgets and limit adoption rates, particularly in emerging markets and smaller healthcare facilities. Additionally, the shortage of qualified radiation oncologists, medical physicists, and trained technicians creates operational constraints that can impede market expansion, while stringent regulatory approval processes for new radiation therapy technologies can delay product launches and market penetration. Despite these challenges, significant opportunities emerge from the expanding healthcare infrastructure in developing nations, increasing government initiatives for cancer care improvement, growing medical tourism for advanced cancer treatments, and the rising adoption of hypofractionated radiation therapy techniques that improve treatment efficiency and patient convenience, positioning the radiation oncology market for sustained long-term growth.
Key Features of the Study
- This report provides in-depth analysis of the global radiation oncology market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global radiation oncology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Varian Medical Systems Inc., Elekta AB, Accuray Incorporated, Mevion Medical Systems, ViewRay Technologies Inc., Isoray Inc., Hitachi Ltd., IBA (Ion Beam Applications SA), Nordion Inc., Brainlab SE, Xstrahl Ltd., Panacea Medical Technologies Pvt. Ltd., Siemens Healthineers AG, GE HealthCare, and Bionix Radiation Therapy LLC.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global radiation oncology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global radiation oncology market
Market Segmentation
- Therapy Type Insights (Revenue, USD Bn, 2020 - 2032)
- External Beam Radiation Therapy (EBRT)
- Internal Beam Radiation Therapy (Brachytherapy/Internal)
- Proton and Heavy Ion Therapy
- Radiopharmaceutical and Systemic Radiation Therapy
- Technology Insights (Revenue, USD Bn, 2020 - 2032)
- 3D Conformal Radiotherapy (3D CRT)
- Intensity Modulated Radiotherapy (IMRT)
- Volumetric Modulated Arc Therapy (VMAT)
- Image Guided Radiotherapy (IGRT)
- Stereotactic Radiotherapy (SRS/SBRT)
- High Dose Rate (HDR)/Low Dose Rate (LDR) Brachytherapy
- Adaptive Radiotherapy/Real Time Tumor Tracking
- Application Insights (Revenue, USD Bn, 2020 - 2032)
- Breast Cancer
- Lung Cancer
- Prostate Cancer
- Head and Neck Cancer
- Colorectal Cancer
- Gynecologic Cancers
- Other Cancers (e.g., skin, brain, pancreas, rare tumors)
- End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals (Cancer/Radiation Therapy Departments)
- Dedicated Oncology and Radiotherapy Centers
- Ambulatory/Outpatient Radiotherapy Clinics
- Research and University Institutes
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Varian Medical Systems Inc.
- Elekta AB
- Accuray Incorporated
- Mevion Medical Systems
- ViewRay Technologies Inc.
- Isoray Inc.
- Hitachi Ltd.
- IBA (Ion Beam Applications SA)
- Nordion Inc.
- Brainlab SE
- Xstrahl Ltd.
- Panacea Medical Technologies Pvt. Ltd.
- Siemens Healthineers AG
- GE HealthCare
- Bionix Radiation Therapy LLC
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Radiation Oncology Market, By Therapy Type
- Global Radiation Oncology Market, By Technology
- Global Radiation Oncology Market, By Application
- Global Radiation Oncology Market, By End User
- Global Radiation Oncology Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Radiation Oncology Market, By Therapy Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- External Beam Radiation Therapy (EBRT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Internal Beam Radiation Therapy (Brachytherapy/Internal)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Proton and Heavy Ion Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Radiopharmaceutical and Systemic Radiation Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Radiation Oncology Market, By Technology, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- 3D Conformal Radiotherapy (3D CRT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Intensity Modulated Radiotherapy (IMRT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Volumetric Modulated Arc Therapy (VMAT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Image Guided Radiotherapy (IGRT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Stereotactic Radiotherapy (SRS/SBRT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- High Dose Rate (HDR)/Low Dose Rate (LDR) Brachytherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Adaptive Radiotherapy/Real Time Tumor Tracking
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Radiation Oncology Market, By Application, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Breast Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Lung Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Prostate Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Head and Neck Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Colorectal Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Gynecologic Cancers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Other Cancers (e.g., skin, brain, pancreas, rare tumors)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Radiation Oncology Market, By End User, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospitals (Cancer/Radiation Therapy Departments)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Dedicated Oncology and Radiotherapy Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Ambulatory/Outpatient Radiotherapy Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Research and University Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Radiation Oncology Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Therapy Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Therapy Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Therapy Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Therapy Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Therapy Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Therapy Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- Varian Medical Systems Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Elekta AB
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Accuray Incorporated
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Mevion Medical Systems
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- ViewRay Technologies Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Isoray Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hitachi Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- IBA (Ion Beam Applications SA)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Nordion Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Brainlab SE
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Xstrahl Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Panacea Medical Technologies Pvt. Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Siemens Healthineers AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GE HealthCare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bionix Radiation Therapy LLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us
机器人放射治疗市场规模、份额和趋势分析报告：按产品、技术、应用、最终用途、地区和细分市场预测（2025-2033 年）
强度调製放射治疗市场－全球产业规模、份额、趋势、机会和预测，按放射类型、应用、最终用户、地区和竞争格局划分，2020-2030年预测
2025年全球自适应放射治疗软体市场报告
重离子治疗技术：全球市场份额和排名、总收入和需求预测（2025-2031 年）
硼中子捕获疗法市场：依产品类型、应用、硼化合物、最终用户和地区划分硼中子捕获疗法（BNCT）：全球市场份额和排名、总销售额和需求预测（2025-2031 年）
放射治疗监测设备市场分析及预测（至2034年）：类型、产品、服务、技术、组件、应用、最终用户和功能
强度调控放射治疗市场（按组件、技术、应用、最终用户和患者类型划分）—2025-2032年全球预测放射治疗设备市场按技术、最终用户和应用划分－2025-2032年全球预测放射肿瘤学市场（按技术、组件、交付模式、应用和最终用户划分）—2025-2032 年全球预测